(Q33872018)

29 July 2017

The association between symptoms and microbiologically defined response to tuberculosis treatment (English)

1 reference

29 July 2017

1 reference

3

Richard Chaisson

1 reference

29 July 2017

Craig M Hales

1

1 reference

29 July 2017

Charles M Heilig

2

1 reference

29 July 2017

Chi Chiu Leung

4

1 reference

29 July 2017

Kwok Chiu Chang

5

1 reference

29 July 2017

Stefan V Goldberg

6

1 reference

29 July 2017

Fred Gordin

7

1 reference

29 July 2017

John L Johnson

8

1 reference

29 July 2017

Grace Muzanyi

9

1 reference

29 July 2017

Jussi Saukkonen

10

1 reference

29 July 2017

Andrew Vernon

11

1 reference

29 July 2017

M Elsa Villarino

12

1 reference

29 July 2017

William J Burman

13

1 reference

29 July 2017

language of work or name

1 reference

1 February 2013

1 reference

Proceedings of the American Thoracic Society

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

1

1 reference

29 July 2017

18-25

1 reference

Clinical symptoms and microbiological outcomes in tuberculosis treatment trials.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Surrogate markers and microbiologic end points

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

A study of the impact of tuberculosis on the quality of life and the effect after treatment with DOTS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Personal and societal health quality lost to tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Measuring health-related quality of life in tuberculosis: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Quality of life in tuberculosis: a review of the English language literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Correlation between bacteriologic and clinical endpoints in trials of acute otitis media

5 July 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201207-038OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201207-038OC

Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201207-038OC

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201207-038OC

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201207-038OC

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5497314

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23509328

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23509328

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1513/ANNALSATS.201207-038OC

1 reference

29 July 2017

1 reference

29 July 2017

1 reference